These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 10942924

  • 1. Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
    Giraldo P, Pocoví M, Pérez-Calvo J, Rubio-Félix D, Giralt M.
    Haematologica; 2000 Aug; 85(8):792-9. PubMed ID: 10942924
    [Abstract] [Full Text] [Related]

  • 2. [Clinical characteristics of type I Gaucher's disease in Spain. Preliminary results of national survey. Spanish Group on Gaucher's Disease].
    Giraldo P, Pérez-Calvo JI, Giralt M, Pocovi M.
    Med Clin (Barc); 1997 Nov 08; 109(16):619-22. PubMed ID: 9463135
    [Abstract] [Full Text] [Related]

  • 3. [Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease].
    Pérez-Calvo JI, Giraldo P, Giralt M.
    Sangre (Barc); 1997 Jun 08; 42(3):189-94. PubMed ID: 9381260
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.
    Andrade-Campos M, Alfonso P, Irun P, Armstrong J, Calvo C, Dalmau J, Domingo MR, Barbera JL, Cano H, Fernandez-Galán MA, Franco R, Gracia I, Gracia-Antequera M, Ibañez A, Lendinez F, Madruga M, Martin-Hernández E, O'Callaghan MDM, Del Soto AP, Del Prado YR, Sancho-Val I, Sanjurjo P, Pocovi M, Giraldo P.
    Orphanet J Rare Dis; 2017 May 03; 12(1):84. PubMed ID: 28468677
    [Abstract] [Full Text] [Related]

  • 5. Residual enzymatic activity as a prognostic factor in patients with Gaucher disease type 1: correlation with Zimran and GAUSS-I index and the severity of bone disease.
    Torralba MA, Olivera S, Bureo JC, Dalmau J, Nuñez R, León P, Villarrubia J.
    QJM; 2016 Jul 03; 109(7):449-52. PubMed ID: 26792850
    [Abstract] [Full Text] [Related]

  • 6. [Type I Gaucher's disease: clinical, evolutive and therapeutic features in 8 cases].
    Giraldo P, Pérez-Calvo J, Cortés T, Civeira F, Rubio-Félix D.
    Sangre (Barc); 1994 Feb 03; 39(1):3-7. PubMed ID: 8197516
    [Abstract] [Full Text] [Related]

  • 7. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
    Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D.
    Health Technol Assess; 2006 Jul 03; 10(24):iii-iv, ix-136. PubMed ID: 16796930
    [Abstract] [Full Text] [Related]

  • 8. Co-morbidity in Gaucher's disease results of a nationwide enquiry in Spain.
    Pérez-Calvo J, Bernal M, Giraldo P, Torralba MA, Civeira F, Giralt M, Pocovi M.
    Eur J Med Res; 2000 Jun 20; 5(6):231-5. PubMed ID: 10882637
    [Abstract] [Full Text] [Related]

  • 9. Velaglucerase alfa for the management of type 1 Gaucher disease.
    Morris JL.
    Clin Ther; 2012 Feb 20; 34(2):259-71. PubMed ID: 22264444
    [Abstract] [Full Text] [Related]

  • 10. Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers).
    Giraldo P, Cenarro A, Alfonso P, Pérez-Calvo JI, Rubio-Félix D, Giralt M, Pocoví M.
    Haematologica; 2001 Sep 20; 86(9):977-84. PubMed ID: 11532627
    [Abstract] [Full Text] [Related]

  • 11. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.
    Damiano AM, Pastores GM, Ware JE.
    Qual Life Res; 1998 Jul 20; 7(5):373-86. PubMed ID: 9691718
    [Abstract] [Full Text] [Related]

  • 12. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J, Szücs FZ, Benkö K, Maródi L.
    Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625
    [Abstract] [Full Text] [Related]

  • 13. Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients.
    Torralba MA, Pérez-Calvo JI, Pastores GM, Cenarro A, Giraldo P, Pocoví M.
    Blood Cells Mol Dis; 2001 Apr 20; 27(2):489-95. PubMed ID: 11259172
    [Abstract] [Full Text] [Related]

  • 14. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
    El-Beshlawy A, Tylki-Szymanska A, Vellodi A, Belmatoug N, Grabowski GA, Kolodny EH, Batista JL, Cox GF, Mistry PK.
    Mol Genet Metab; 2017 Apr 20; 120(1-2):47-56. PubMed ID: 28040394
    [Abstract] [Full Text] [Related]

  • 15. Baseline characteristics and outcome in Romanian patients with Gaucher disease type 1.
    Grigorescu-Sido P, Drugan C, Alkhzouz C, Zimmermann A, Coldea C, Denes C, Grigorescu MD, Cret V, Bucerzan S.
    Eur J Intern Med; 2010 Apr 20; 21(2):104-13. PubMed ID: 20206881
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gaucher disease in Spanish patients: analysis of eight mutations.
    Cormand B, Vilageliu L, Burguera JM, Balcells S, Gonzàlez-Duarte R, Grinberg D, Chabás A.
    Hum Mutat; 1995 Apr 20; 5(4):303-9. PubMed ID: 7627184
    [Abstract] [Full Text] [Related]

  • 18. [Effect of enzyme replacement therapy on lipid profile in patients with Gaucher's disease].
    Alfonso P, Cenarro A, Pérez-Calvo JI, Puzo J, Giralt M, Giraldo P, Pocoví M.
    Med Clin (Barc); 2003 May 10; 120(17):641-6. PubMed ID: 12747811
    [Abstract] [Full Text] [Related]

  • 19. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.
    Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, Zimran A.
    Arch Intern Med; 2000 Oct 09; 160(18):2835-43. PubMed ID: 11025794
    [Abstract] [Full Text] [Related]

  • 20. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 09; 44(9):653-6. PubMed ID: 17217655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.